Paper Details

  1. Home
  2. Paper Details

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

Author: FlaigM, HerzingerT, KapserC, MolinS, RuzickaT

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Alitretinoin was well tolerated and showed a good clinical response in patients with cutaneous T-cell lymphoma. 90.9% of patients showed marked improvement of their skin lesions.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Cutaneous T-cell lymphoma (CTCL) is a potentially life-limiting malignant disease. Treatment strategies in CTCL aim at disease control and remission with the lowest possible side-effects. OBJECTIVE: Recent reports suggest that the new vitamin A derivative alitretinoin might be a well-to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jdv.12684

データ提供：米国国立医学図書館（NLM）

Oral Alitretinoin: A New Oasis in the Desert of Cutaneous T-Cell Lymphoma Treatment

Cutaneous T-cell lymphoma (CTCL) is a serious type of skin cancer, like a persistent sandstorm that threatens the skin's health. This 2014 study investigated the efficacy and safety of oral alitretinoin, a vitamin A derivative, in treating CTCL. This research, like a caravan searching for a new source of water, aimed to find a less toxic and more effective treatment option for this challenging condition.

A Promising New Approach: A Cool Spring in the Desert

The study found that oral alitretinoin was well-tolerated and showed a good clinical response in most patients with CTCL. This is like finding a cool spring in the desert, providing relief and a path to recovery. While some patients experienced mild side effects, the overall response to treatment was positive, indicating that this drug could be a valuable addition to the treatment arsenal for CTCL. This discovery is like finding a hidden oasis in the desert of CTCL treatment, offering a new and promising path forward.

A Hopeful Future for CTCL Patients

This study suggests that oral alitretinoin could be a valuable treatment option for patients with CTCL. This is like finding a new source of water in the desert, offering hope for a more manageable and potentially longer life. While further research is needed to confirm these findings, this study offers a beacon of hope for those living with this challenging condition.

Dr.Camel's Conclusion

This study provides promising evidence that oral alitretinoin could be a safe and effective treatment for CTCL, offering a new oasis of hope in the desert of this serious skin cancer.

Date :
  1. Date Completed 2016-01-26
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25175592

DOI: Digital Object Identifier

10.1111/jdv.12684

Related Literature

Article Analysis
・Side Effects of alitretinoin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.